Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Bicycle Therapeutics plc - American Depositary Shares (NQ:BCYC)

3.990 -0.010 (-0.25%)

Streaming Delayed Price Updated: 12:32 PM EDT, Jun 22, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	175,174
Open	3.990
Bid (Size)	3.990 (500)
Ask (Size)	4.000 (500)
Prev. Close	4.000
Today's Range	3.960 - 4.070
52wk Range	3.950 - 9.183
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Bicycle Therapeutics to Present Initial Duravelo-2 Data at 2026 ASCO Annual Meeting

May 21, 2026

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results

April 30, 2026

From Bicycle Therapeutics plc

Via Business Wire

Performance

YTD	-40.3%	-40.3%
1 Month	-12.3%	-12.3%
3 Month	-8.1%	-8.1%
6 Month	-44.5%	-44.5%
1 Year	-44.8%	-44.8%

More News

Bicycle Therapeutics Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting

April 21, 2026

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Provides Update on Nuzefatide Pevedotin and EphA2 Pipeline at the AACR Annual Meeting 2026

April 20, 2026

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Announces Oral and Poster Presentations at the AACR Annual Meeting 2026

March 18, 2026

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results

March 17, 2026

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Announces Leadership Transitions for Next Phase of Innovation Across Oncology Pipeline

February 03, 2026

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Highlights 2025 Accomplishments and Strategic Priorities for 2026

January 12, 2026

From Bicycle Therapeutics plc

Via Business Wire

The Great Migration: Why International Tech and Biotech Giants are Redomiciling to the Massachusetts Hub

December 23, 2025

Via MarketMinute

Bicycle Therapeutics Establishes Multiple Strategic Partnerships to Create End-to-End Supply Chain to Support its Wholly Owned Radiopharmaceutical Pipeline

December 16, 2025

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference

November 12, 2025

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results

October 30, 2025

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Strengthens Board of Directors with New Appointments

September 08, 2025

From Bicycle Therapeutics plc

Via Business Wire

4 Analysts Assess Bicycle Therapeutics: What You Need To Know ↗

August 12, 2025

Via Benzinga

Bicycle (BCYC) Q2 Revenue Falls 69% ↗

August 08, 2025

Via The Motley Fool

Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results

August 08, 2025

From Bicycle Therapeutics plc

Via Business Wire

Demystifying Bicycle Therapeutics: Insights From 7 Analyst Reviews ↗

July 17, 2025

Via Benzinga

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 02, 2025

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 03, 2025

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Announces Poster Presentations at the 2025 ASCO Annual Meeting

May 22, 2025

From Bicycle Therapeutics

Via Business Wire

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 05, 2025

From Bicycle Therapeutics plc

Via Business Wire

A Glimpse Into The Expert Outlook On Bicycle Therapeutics Through 7 Analysts ↗

May 02, 2025

Via Benzinga

Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results

May 01, 2025

From Bicycle Therapeutics plc

Via Business Wire

Bicycle Therapeutics Announces Presentation of Additional Human Radiopharmaceutical Imaging Data for MT1-MMP at the American Association for Cancer Research Annual Meeting 2025

April 29, 2025

From Bicycle Therapeutics plc

Via Business Wire

Analyst Expectations For Bicycle Therapeutics's Future ↗

April 09, 2025

Via Benzinga

Frequently Asked Questions

Is Bicycle Therapeutics plc - American Depositary Shares publicly traded?

Yes, Bicycle Therapeutics plc - American Depositary Shares is publicly traded.

What exchange does Bicycle Therapeutics plc - American Depositary Shares trade on?

Bicycle Therapeutics plc - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Bicycle Therapeutics plc - American Depositary Shares?

The ticker symbol for Bicycle Therapeutics plc - American Depositary Shares is BCYC on the Nasdaq Stock Market

What is the current price of Bicycle Therapeutics plc - American Depositary Shares?

The current price of Bicycle Therapeutics plc - American Depositary Shares is 3.990

When was Bicycle Therapeutics plc - American Depositary Shares last traded?

The last trade of Bicycle Therapeutics plc - American Depositary Shares was at 06/22/26 12:32 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.